🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

M-Tapa Block and Transversus Abdominal Plane Block for Postoperative Analgesia in Unilateral Open Inguinal Hernia Repair Surgery

RecruitingNAAges 18 Years - 65 YearsAllErzurum Regional Training & Research Hospital
NCT07311902 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients will be called to the operating room one hour before surgery and no premedication will be applied before coming to the operating room. Patients in both groups who are taken to the block room will be administered 1-2 mg iv midazolam for sedation. M TAPA block will be applied for the surgical procedure. After aseptic conditions are provided, the high-frequency linear US probe will be covered with a sterile sheath. The US probe will be placed in the saggital plane at the costochondral angle where the midclavicular line intersects the costal cartilage. 5 ml of saline will be injected using the in-plane technique using a 22G 100 mm block needle and the block location will be verified. After the block location is verified, a total of 20 ml of 0.25% bupivacaine will be injected unilaterally and the procedure will be terminated. After aseptic conditions are provided, the high-frequency

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Exclusion Criteria: * History of bleeding diathesis * Allergy or sensitivity to local anesthetics and opioids * Infection in the area where the block will be applied * Alcohol or drug addiction * Patients with a BMI \> 30 * Suspected pregnancy * Women in pregnancy or lactation * Patients with allergies to study drugs * Patient refusal * Use of anticoagulant agents Inclusion Criteria: * Planning for elective unilateral open inguinal hernia repair surgery * ASA I-II status * Being between 18 and 65 years of age
💊

What it tests

  • TAP Block Group
  • M TAPA block
📍

Where

1 site
Erzurum Regional Education and Research Hospital
Erzurum, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy